Glutathione Deficiency

Glutathione deficiency is a rare genetic disorder that impacts the body's ability to produce a crucial molecule called glutathione. Often referred to as the "master antioxidant," glutathione plays a vital role in protecting our cells from damage, detoxifying harmful substances, supporting immune function, and maintaining overall cellular health. When the body cannot produce enough functional glutathione due to a genetic fault, it can lead to a range of health problems, from mild to severe. Understanding this complex condition is the first step towards effective management and improving the quality of life for those affected. 

Glutathione deficiency is a metabolic disorder characterised by the body's inability to produce sufficient levels of glutathione. Glutathione is a tripeptide, meaning it's made up of three amino acids: cysteine, glycine, and glutamic acid. It's naturally produced in the liver and is present in almost every cell in the body. Its primary functions include:

• Antioxidant defence: Glutathione neutralises harmful unstable molecules called free radicals, which are byproducts of normal bodily processes and environmental exposures. Without adequate glutathione, cells are more susceptible to oxidative stress and damage.
• Detoxification: It helps the body eliminate toxins, heavy metals, and various drugs by binding to them, making them water-soluble, and facilitating their excretion.
• Immune system support: Glutathione is essential for the proper functioning of immune cells, helping them fight off infections and diseases.
• Protein and DNA synthesis: It plays a role in the building blocks of our cells and genetic material.

In glutathione deficiency, a genetic mutation, specifically in the GSS gene, impairs the function of the enzyme glutathione synthetase. This enzyme is critical for the final step in glutathione production. As a result, individuals with this deficiency have abnormally low levels of glutathione, leading to a build-up of harmful byproducts like 5-oxoproline (also known as pyroglutamic acid) and increased vulnerability to cellular damage.

Glutathione synthetase deficiency is typically classified into three main types, based on the severity of symptoms and the level of enzyme activity:

• Mild Glutathione Synthetase Deficiency: This form usually presents with the least severe symptoms, primarily characterised by chronic haemolytic anaemia (destruction of red blood cells). Individuals may also excrete excessive amounts of 5-oxoproline in their urine (5-oxoprolinuria), but often maintain sufficient cellular glutathione levels to prevent severe accumulation of harmful compounds in bodily fluids.
• Moderate Glutathione Synthetase Deficiency: Symptoms typically begin shortly after birth. In addition to haemolytic anaemia and 5-oxoprolinuria, affected individuals often experience metabolic acidosis, which is an elevated acidity in the blood and tissues.
• Severe Glutathione Synthetase Deficiency: This is the most serious form, presenting with all the features of moderate deficiency, plus progressive neurological symptoms. These can include seizures, psychomotor retardation (a generalised slowing down of physical reactions, movements, and speech), intellectual disability, and ataxia (loss of coordination). Some individuals with severe glutathione synthetase deficiency may also experience recurrent bacterial infections due to impaired immune function.

Glutathione deficiency is primarily caused by genetic mutations that affect the body's ability to synthesise glutathione. The most common cause is a mutation in the GSS gene. This gene provides the instructions for making the enzyme glutathione synthetase, which is crucial for the final step in the production of glutathione.

The inheritance pattern for glutathione synthetase deficiency is autosomal recessive. This means that an individual must inherit two copies of the mutated GSS gene—one from each parent—to develop the condition. If a person inherits only one copy of the mutated gene, they are considered a carrier. Carriers typically do not show symptoms of the deficiency themselves but can pass the gene on to their children. If both parents are carriers, there is a 25% chance with each pregnancy that their child will inherit two mutated copies and develop glutathione deficiency.

Beyond this primary genetic cause, other, even rarer, inborn errors in the metabolism of glutathione can also lead to deficiency, affecting different enzymes involved in the glutathione pathway. Additionally, while not a direct cause of the genetic deficiency, certain factors can lead to acquired or secondary glutathione depletion, such as chronic illness, poor nutrition, exposure to toxins, and ageing. However, the term "glutathione deficiency" typically refers to the inherited form.

The symptoms of glutathione deficiency vary widely depending on the severity of the condition, often correlating with the amount of residual enzyme activity. They can appear shortly after birth or develop later in infancy. Common signs and symptoms include:

• Haemolytic anaemia: This is a consistent feature, leading to pale skin (pallor), jaundice (yellowing of the skin and eyes), and fatigue due to the premature destruction of red blood cells.
• Metabolic acidosis: A build-up of acid in the body, which can cause symptoms like rapid breathing, vomiting, and lethargy. This is particularly noticeable in moderate and severe forms.
• 5-oxoprolinuria: The excretion of large amounts of 5-oxoproline in the urine, which can be detected through specific tests.
• Neurological problems: In severe cases, these can be profound and include developmental delay, intellectual disability, seizures, spasticity (stiff muscles), and ataxia (lack of coordination).
• Recurrent infections: Due to impaired immune function, individuals with severe deficiency may experience frequent bacterial infections.
• Failure to thrive: Infants may not gain weight or develop at the expected rate.

Diagnosing glutathione deficiency typically involves a combination of clinical assessment, laboratory tests, and genetic testing. Given its rarity, it may not be immediately suspected, especially in milder cases.

The diagnostic process often includes:

• Clinical evaluation: A doctor will assess the patient's symptoms, medical history, and family history. The presence of haemolytic anaemia, metabolic acidosis, or unexplained neurological symptoms in infants or young children can raise suspicion.
• Urine test for 5-oxoproline: Elevated levels of 5-oxoproline (pyroglutamic acid) in the urine are a key indicator of glutathione synthetase deficiency. This compound accumulates when glutathione is not processed correctly.
• Blood tests for glutathione levels: Measuring the concentration of glutathione in red blood cells or whole blood can confirm low levels.
• Enzyme activity assay: This test measures the activity of the glutathione synthetase enzyme in red blood cells or other tissues. Low enzyme activity confirms the deficiency.
• Genetic testing: Analysis of the GSS gene can identify specific mutations responsible for the condition, providing a definitive diagnosis and allowing for genetic counselling for the family. Newborn screening programmes in some regions may also include screening for elevated 5-oxoproline, which can lead to early detection.

As of now, there is no cure for glutathione synthetase deficiency. Treatment focuses on managing the symptoms, preventing complications, and supporting the body's antioxidant defence system. The management plan is highly individualised and depends on the type and severity of the deficiency.

Key treatment strategies include:

• Correction of metabolic acidosis: For individuals with moderate or severe forms, chronic metabolic acidosis is a significant concern. This is typically managed with oral bicarbonate therapy (e.g., sodium bicarbonate) to neutralise excess acid in the body.
• Antioxidant supplementation: Supplementation with antioxidants, particularly high doses of vitamin C (ascorbic acid) and vitamin E, is often recommended. These vitamins can help to reduce oxidative damage caused by the low glutathione levels. N-acetylcysteine (NAC) is also sometimes used as it is a precursor to glutathione, potentially aiding in its synthesis, though its effectiveness in genetic glutathione deficiency can vary.
• Supplements: Dietary supplements containing glutathione (Brand: Maxiliv, Theotres) may be prescribed to address the deficiency.
• Blood transfusions: For severe haemolytic anaemia, regular blood transfusions may be necessary to maintain adequate red blood cell levels.
• Management of neurological symptoms: For severe forms with neurological involvement, treatment is supportive and may include anti-seizure medications, physical therapy, occupational therapy, and speech therapy to help manage symptoms and improve developmental outcomes.
• Infection prevention: Due to increased susceptibility to infections in severe cases, proactive measures and prompt treatment of infections are vital.
• Avoidance of certain drugs: Patients are often advised to avoid medications known to cause oxidative stress or precipitate haemolytic crises, similar to precautions taken in glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Long-term follow-up with a multidisciplinary team, including a metabolic specialist, haematologist, and neurologist, is essential for comprehensive care. Early diagnosis and consistent adherence to treatment are crucial for improving long-term outcomes and survival.

• Inheriting two copies of a mutated GSS gene (autosomal recessive inheritance).
• Both parents being carriers of the GSS gene mutation.
• Family history of glutathione synthetase deficiency.

• Chronic haemolytic anaemia leading to severe fatigue and jaundice.
• Severe metabolic acidosis, potentially life-threatening if untreated.
• Progressive neurological damage, including intellectual disability and seizures.
• Increased susceptibility to severe and recurrent infections.
• Retinal dystrophy (eye damage) in some adult patients.
• Failure to thrive and developmental delays in children.

Living with glutathione deficiency requires careful management and a proactive approach to health. Here are five tips to help individuals and their families navigate the condition:

• Strictly adhere to medical treatment: Follow your doctor's prescribed regimen for bicarbonate therapy, antioxidant supplements, and any other medications to manage symptoms and prevent complications.
• Maintain regular medical appointments: Consistent follow-up with your metabolic specialist, haematologist, and other healthcare professionals is crucial for monitoring the condition and adjusting treatment as needed.
• Be vigilant for signs of complications: Learn to recognise symptoms of worsening acidosis, anaemia, or infections, and seek immediate medical attention if they occur.
• Educate your support network: Ensure family, friends, and caregivers understand the condition and how to respond in an emergency.
• Prioritise a healthy lifestyle: While it won't cure the deficiency, a balanced diet and appropriate physical activity can support overall health and well-being.

Myth: Glutathione deficiency is common. 

In reality, inherited glutathione synthetase deficiency is a very rare genetic disorder, affecting fewer than 1 in a million people.

Myth: You can cure glutathione deficiency with diet or supplements alone. 

While antioxidant supplements and a healthy diet can support overall health and help manage symptoms, they cannot cure the underlying genetic defect or fully replace the body's natural glutathione production. Medical treatment, such as bicarbonate therapy, is essential.

Myth: All low glutathione levels mean you have this genetic deficiency. 

Low glutathione levels can be a secondary effect of many chronic illnesses, ageing, or environmental factors. True glutathione deficiency refers specifically to the rare inherited disorder caused by a genetic mutation affecting its synthesis.

It is crucial to see a doctor if you or your child exhibits symptoms suggestive of glutathione deficiency, especially in infancy. These include persistent haemolytic anaemia (paleness, jaundice), unexplained metabolic acidosis (rapid breathing, vomiting, lethargy), developmental delays, seizures, or recurrent infections. Given the rarity of the condition, it's important to provide your doctor with a comprehensive family medical history, particularly if there's any known history of similar unexplained symptoms or metabolic disorders. 

Early diagnosis and intervention are critical for managing the condition and preventing severe, long-term complications. If you are already diagnosed, consult your healthcare team for any new or worsening symptoms, or if you have concerns about your treatment plan.

• What specific type of glutathione deficiency do I/my child have, and what does that mean for the prognosis?
• What is the long-term treatment plan, and how often will we need follow-up appointments and tests?
• What are the potential side effects of the prescribed medications (e.g., bicarbonate, antioxidants), and what should I watch out for?
• What are the emergency signs of metabolic acidosis or haemolytic crisis, and what steps should I take if they occur?
• Are there any specific dietary recommendations or restrictions that could help manage the condition?
• What resources or support groups are available for families dealing with a rare metabolic disorder like this?
• Should other family members be tested for carrier status or the deficiency itself?

Glutathione deficiency, especially the inherited type called glutathione synthetase deficiency, is a rare but serious condition that affects the body’s natural way of fighting damage and staying healthy. It can cause many health problems, especially in severe cases. However, with better medical knowledge and supportive treatments, there is hope for living a better life. Early diagnosis, regular check-ups, and proper care are very important.